Who founded Rocket Pharma?

Rocket Pharma was founded by Gaurav Shah in 2015.

Who are Rocket Pharma's investors?

Rocket Pharma's investors include Avoro Capital Advisors, Broadview Ventures, Civilization Ventures Management, Llc, RTW Investments L.P..

How much funding has Rocket Pharma raised?

Rocket Pharma has disclosed $41.6M raised across 2 rounds.

Rocket Pharma

Founded 2015 · Incorporated in Cayman Islands · 223 employees on LinkedIn · 4 known investors

Find your way into Rocket Pharma

348 people in our graph share verified history with the Rocket Pharma team — schools, employers, funds. One of them is your warm intro.

Adam Valkinunlockedknows Gaurav Shah · together at Harvard University (overlapped)

×10knows the team · via Harvard University

knows the team · via Columbia University Medical Center

Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders. The company creates potentially curative treatments at the genetic level for inherited and rare diseases.

Biotech Digital Health Medical Devices

Founders & leadership

Rocket Pharma was founded in 2015 by Gaurav Shah.

Gaurav Shah inCo-founder & Chief Executive OfficerGaurav Shah trained as a medical oncologist and neuro-oncologist at Harvard and Memorial Sloan-Kettering; he previously held roles at Novartis including Global Program Head for the CART-19 cell and gene therapy unit, where he led pivotal trials in CAR-T therapies for hematologic malignancies, and earlier served as Medical Director at ImClone/Eli Lilly overseeing oncology trials.

Board

Roderick Wong in 𝕏Board directorManaging Partner, CIO at RTW Investments L.P.

Naveen Yalamanchi in 𝕏Co-Founder and Board Director2015–2025Partner, Portfolio Manager at RTW Investments L.P.

Investors · 4

Avoro Capital AdvisorsNew York

Broadview VenturesBoston

Civilization Ventures Management, LlcTiburon · $1M – $10M

RTW Investments L.P.reportedNew Yorkvia Naveen Yalamanchi · board

Reported raises · per SEC filings

Form D private placements

$41.6M disclosed across 2 rounds · 2015–2017

▶$25.1MraisedMay 2017 · 15 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Naveen YalamanchiDirector
Gaurav ShahExecutive Officer
Roderick WongDirector

Offering amount: $30.1M
Amount sold: $25.1M
Minimum investment: $24K
First sale: Feb 2017
Incorporated: Other, Cayman Islands, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$16.4MraisedJan 2016 · 16 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Roderick WongDirector
Gaurav ShahExecutive Officer
Naveen YalamanchiDirector

Offering amount: $38M
Amount sold: $16.4M
Minimum investment: $75K
First sale: Dec 2015
Incorporated: Other, Cayman Islands, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Robinhood47 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.

Thumbnail for Seragon Pharmaceuticals45 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.

Companies competing with Rocket Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Rocket Pharma shares fall despite FDA nod for childhood disorder treatment | Reutersreuters.com · Mar 2026

Frequently asked questions

What does Rocket Pharma do?: Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders. The company creates potentially curative treatments at the genetic level for inherited and rare diseases.
Who founded Rocket Pharma?: Rocket Pharma was founded by Gaurav Shah in 2015.
Who are Rocket Pharma's investors?: Rocket Pharma's investors include Avoro Capital Advisors, Broadview Ventures, Civilization Ventures Management, Llc, RTW Investments L.P..
How much funding has Rocket Pharma raised?: Rocket Pharma has disclosed $41.6M raised across 2 rounds.